SCHEMBL363707

SCHEMBL363707

COC(=O)c1ccc(C(C/C(=N\O)c2ccnc(C)c2)c2ccc(F)cc2F)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 5/20 0.67
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
DPP4 P27487 2/20 0.36
CYP26A1 O43174 2/20 0.35
CYP3A4 P08684 2/20 0.35
KDM4E B2RXH2 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ALOX15 P16050 1/20 0.34
KDM6B O15054 1/20 0.34
KDM5C P41229 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM2A Q9Y2K7 1/20 0.34
KDM3A Q9Y4C1 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM5A P29375 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1390565 1.00 GPBAR1 (0.67) GPBAR1NPC1LMNAMAPTRAB9A
SCHEMBL1390315 0.91 GPBAR1 (0.71) GPBAR1NPC1RAB9ASMN1; SMN2CYP26A1
SCHEMBL363095 0.91 GPBAR1 (0.71) GPBAR1NPC1RAB9ASMN1; SMN2CYP26A1
SCHEMBL1390314 0.91 GPBAR1 (0.71) GPBAR1NPC1RAB9ASMN1; SMN2CYP26A1
SCHEMBL363810 0.89 GPBAR1 (0.52) GPBAR1NPC1LMNAMAPTRAB9A
SCHEMBL1390279 0.87 GPBAR1 (0.62) GPBAR1LMNAMAPTL3MBTL1MEN1
SCHEMBL361774 0.87 GPBAR1 (0.62) GPBAR1LMNAMAPTL3MBTL1MEN1
SCHEMBL1390277 0.87 GPBAR1 (0.62) GPBAR1LMNAMAPTL3MBTL1MEN1
SCHEMBL1389995 0.86 GPBAR1 (0.63) GPBAR1MEN1KMT2AMAPK14EPHX2
SCHEMBL1389999 0.86 GPBAR1 (0.63) GPBAR1MEN1KMT2AMAPK14EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885NPC1 1074/4885LMNA 2651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.